Acorda Therapeutics Cdt buy StockNews.com
Start price
31.05.23
/
50%
€0.58
Target price
31.05.24
-
Performance (%)
-18.97%
End price
01.06.24
-
Summary
This prediction is currently being closed. The prediction for Acorda Therapeutics Cdt disappoints with a performance of -18.97%. StockNews_com has a follow-up prediction for Acorda Therapeutics Cdt where he still thinks Acorda Therapeutics Cdt is a Buy. StockNews_com has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Acorda Therapeutics Cdt | - | - | - |
iShares Core DAX® | -1.114% | 3.430% | 25.966% |
iShares Nasdaq 100 | 1.816% | 6.911% | 30.390% |
iShares Nikkei 225® | 2.113% | 5.501% | 23.404% |
iShares S&P 500 | 2.038% | 5.327% | 30.881% |
Comments by StockNews_com for this prediction
In the thread Acorda Therapeutics Cdt diskutieren
Acorda Therapeutics, Inc. (NASDAQ: ACOR) is now covered by analysts at StockNews.com. They set a "buy" rating on the stock.
Ratings data for ACOR provided by MarketBeat
In the thread Trading Acorda Therapeutics Cdt
Die von StockNews_com gewählte maximale Laufzeit wurde überschritten
Current prediction by StockNews_com for Acorda Therapeutics Cdt
Stopped prediction by StockNews_com for Acorda Therapeutics Cdt
Acorda Therapeutics Cdt
Start price
Target price
Perf. (%)
€0.61
07.05.23
07.05.23
-
07.05.24
07.05.24
-22.31%
08.05.24
08.05.24
Acorda Therapeutics Cdt
Start price
Target price
Perf. (%)
€0.41
29.04.23
29.04.23
-
29.04.24
29.04.24
10.78%
30.04.24
30.04.24